Current Bladder Dysfunction Reports

, Volume 8, Issue 1, pp 45–50 | Cite as

Objective Evaluation of Overactive Bladder: Which Surveys Should I Use?

  • Michael Shy
  • Sophie G. Fletcher
Overactive Bladder (A Klausner, Section Editor)


Overactive bladder (OAB) is a common condition that affects many adults, and prevalence increases with age in both men and women. It is characterized by symptoms of urinary frequency and urgency with or without urge incontinence in the absence of another proven etiology. As a diagnosis based solely on urinary symptoms, proper evaluation of OAB often depends on the use of psychometrically validated questionnaires to assess symptom severity and degree of bother. General urinary assessment forms can evaluate many urinary symptoms while modular questionnaires can focus on the most bothersome complaints. Many questionnaires have been formulated and validated to achieve these goals. Currently, the ideal questionnaire does not exist. This review attempts to outline the range of questionnaires available to the clinician to assist in evaluating symptoms as well as degree of impact on quality of life.


Overactive bladder Lower urinary tract symptoms (LUTS) Urinary incontinence Questionnaire Quality of life (QOL) 



No potential conflicts of interest related to this article were reported.


  1. 1.
    Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50:1306–14. discussion 14-5.PubMedCrossRefGoogle Scholar
  2. 2.
    Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20:327–36.PubMedGoogle Scholar
  3. 3.
    Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167–78.PubMedCrossRefGoogle Scholar
  4. 4.
    Tubaro A, Palleschi G. Overactive bladder: epidemiology and social impact. Curr Opin Obstet Gynecol. 2005;17:507–11.PubMedCrossRefGoogle Scholar
  5. 5.
    Milsom I, Abrams P, Cardozo L, et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87:760–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Donovan J, Bosch R, Gotoh M, et al. Symptom and quality of life assessment. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence: Proceedings of the Third International Consultation on Incontinence, June 26–29, 2004. 3rd ed. Plymouth: Health Publication; 2005. p. 519–84.Google Scholar
  7. 7.
    Aaronson NK. Quality of life assessment in clinical trials: methodologic issues. Control Clin Trials. 1989;10:S195.CrossRefGoogle Scholar
  8. 8.
    Avery KN, Bosch JL, Gotoh M, et al. Questionnaires to assess urinary and anal incontinence: review and recommendations. J Urol. 2007;177(1):39–49.PubMedCrossRefGoogle Scholar
  9. 9.
    Hyman MJ, Groutz A, Blaivas JG. Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings. J Urol. 2001;166(2):550–2.PubMedCrossRefGoogle Scholar
  10. 10.
    Khan MS, Chaliha C, Leskova L, et al. The relationship between urinary symptom questionnaires and urodynamic diagnoses: an analysis of two methods of questionnaire administration. BJOG. 2004;111(5):468–74.PubMedCrossRefGoogle Scholar
  11. 11.
    Albo M, Wruck L, Baker J, et al. The relationships among measures of incontinence severity in women undergoing surgery for stress urinary incontinence. J Urol. 2007;177(5):1810–4.PubMedCrossRefGoogle Scholar
  12. 12.
    On SJ, Ku JH. Comparative study of international prostate symptom scores and urodynamic parameters in men and women with lower urinary tract symptoms. Urol Int. 2006;76(4):309–13.PubMedCrossRefGoogle Scholar
  13. 13.
    Fayers P, de Haes J. Quality of life and clinical trials. Lancet. 1995;346:1.CrossRefGoogle Scholar
  14. 14.
    Penson DF, Litwin MS. Quality of life assessment in urology. Contemp Urol. 1997;9:53–66.Google Scholar
  15. 15.
    Testa MA, Simonson DC. Assessment of quality of life outcomes. N Engl J Med. 1996;334:835–40.PubMedCrossRefGoogle Scholar
  16. 16.
    Kelly CE. Which questionnaires should be used in female urology practice? Curr Urol Rep. 2003;4(5):375–80.PubMedCrossRefGoogle Scholar
  17. 17.
    Lepor H, Machi G. Comparison of AUA Symptom Index in unselected males and females between fifty-five and seventy-nine years of age. Urology. 1993;42:36–41.PubMedCrossRefGoogle Scholar
  18. 18.
    Chai TC, Belville WD, McGuire EJ, et al. Specificity of the American Urological Association Voiding Symptom Index: comparison of unselected and selected samples of both sexes. J Urol. 1993;150:1710–3.PubMedGoogle Scholar
  19. 19.
    Scarpero HM, Fiske J, Nitti VW. The American Urological Association Symptom Index for lower urinary tract symptoms in women: correlation with degree of bother and impact on quality of life [Abstract]. J Urol. 2002;167:76.Google Scholar
  20. 20.
    Shumaker SA, Wyman JF, Uebersax JS, et al. Health-related quality of life measures for women with urinary incontinence: the urogenital distress inventory and the incontinence impact questionnaire. Quality Life Res. 1994;3:291–306.CrossRefGoogle Scholar
  21. 21.
    Hagen S, Hanley J, Capewell A. Test-retest reliability, validity, and sensitivity to change of the urogenital distress inventory and the incontinence impact questionnaire. Neurourol Urodyn. 2002;21(6):534–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Uebersax JS, Wyman JF, Shumaker SA, et al. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn. 1995;14(2):131–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Jackson S, Donovan J, Brookes S, et al. The Bristol Female Lower Urinary Tract Symptoms Questionnaires: development and psychometric testing. Br J Urol. 1996;7:805–12.Google Scholar
  24. 24.
    Coyne K, Revicki D, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. 2002;11(6):563–74.PubMedCrossRefGoogle Scholar
  25. 25.
    Matza LS, Thompson CL, Krasnow J, et al. Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ). Neurourol Urodyn. 2005;24(3):215–25.PubMedCrossRefGoogle Scholar
  26. 26.
    Coyne KS, Schmier J, Hunt T, et al. Developing a specific HRQL instrument for overactive bladder. Value Health. 2000;3:141.CrossRefGoogle Scholar
  27. 27.
    Coyne K, Matza LS, Versi E. Urinary urgency: Can “gotta go” be measured? Poster presented at the 10th Annual Meeting of the International Society for Quality of Life Research, Prague, Czech Republic, 2003.Google Scholar
  28. 28.
    Weinberger M, Oddone EZ, Henderson WG. Does increased access to primary care reduce hospital readmissions? Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission. N Engl J Med. 1996;334:1441–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Piault E, Evans CJ, Espindle D, et al. Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire. Neurourol Urodyn. 2008;27(3):179–90.PubMedCrossRefGoogle Scholar
  30. 30.
    Donovan J, Naughton M, Gotoh M, et al. Symptom and quality of life assessment. In: Khoury S, Wein A, editors. Incontinence: Proceedings of the First International Consultation on Incontinence, June 28 – July 1, 1998 Plymouth. UK: Health Publication; 1999. p. 295–331.Google Scholar
  31. 31.
    Donovan J, Badia X, Corcos J, et al. Symptom and quality of life assessment. In: Cardozo L, Khoury S, Wein A, editors. Incontinence: Proceedings of the Second International Consultation on Incontinence, July 1-3, 2001. 2nd ed. Plymouth: Health Publication; 2002. p. 267–316.Google Scholar
  32. 32.
    Avery K, Donovan J, Peters TJ, et al. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322–30.PubMedCrossRefGoogle Scholar
  33. 33.
    Abrams P, Avery K, Gardener N, et al. The international consultation on incontinence modular questionnaire: J Urol. 2006;175(3 Pt 1):1063-6; discussion 1066.Google Scholar
  34. 34.
    Donovan JK, Abrams P, Peters TJ, et al. The ICS-‘BPH’ study: the psychometric validity and reliability of the ICSmale questionnaire. Br J Urol. 1996;77:554.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Scott Department of UrologyBaylor College of MedicineHoustonUSA
  2. 2.Department of UrologyWeill-Cornell Medical CollegeNew YorkUSA
  3. 3.The Methodist Hospital, Center for Restorative Pelvic MedicineHoustonUSA

Personalised recommendations